NIH’s NCCAM has been renamed the National Center for Complementary and Integrative Health (NCCIH). The name change, included in the Congressional omnibus budget, is meant to reflect the reality that most people don’t use ‘alternative medicine.’ It’s more common to bring together conventional and complementary approaches to health care. The new name speaks to the importance, according to NIH director Francis Collins, M.D., Ph.D., of bringing a scientific approach to the health and wellness practices … Read More
NIH is seeking time-sensitive input on various initiatives within four separate Institutes: National Library of Medicine (NLM): NIH Director Working Group deliberations In order to chart the course for the future of the world’s largest biomedical library, the NIH Director established a working group to review the current state of the NLM as well as to articulate a strategic vision for its future as an international leader in biomedical and health information. Comments are being … Read More
On Jan. 12, 2015, the NIH released an announcement that provides an updated diversity statement, describing the institutes’s interest in the diversity of the NIH-funded workforce. The statement provides recent data (updated in 2014) on underrepresented populations in the U.S. biomedical research community and encourages institutions to diversify their student and faculty populations. The statement highlighted the under-representation of women at senior faculty levels in biomedical-relevant disciplines. A new provision was also included that allows … Read More
Need budget guidance for NIH awards? Here’s the latest: Funding levels for noncompeting renewals, which have been at about 90% of award, will likely be restored. Those that have yet to be awarded may be awarded in a range between full commitment level to 3% below. See your specific IC for more information. NRSA stipends will increase by about 2%. New investigators should still retain their ‘bonus’. Salaries are capped at $183,300. Responses to more … Read More
The salary cap for NIH awards will increase from $181,500 to $183,300, beginning January 11, 2015. What does this mean for you? See examples and scenarios in the full notice or talk to your OPAM representative.
The new levels for stipends, tuition, institutional allowances, and other relevant budget items have now been updated for all Ruth L. Kirschstein (NRSA) and T32 (and other institutional training) awards. See the full notice here.
The National Institutes of Health is changing its standard application dates for SBIRs/STTRs to speed up the disbursal of funds to successful applicants. The current deadlines are April 5, August 5, and December 5. Beginning in September 2015, the new dates will be September 5, January 5, and April 5. Essentially, this means that the next two deadlines for this mechanism are April 5, 2015, and September 5, 2015, with the August 5 deadline being eliminated. … Read More
The National Institutes of Health has updated and simplified its policy on submitting late applications, beginning with applications due January 25, 2015 or later. They have added a two week window after the due date during which a request to accept a late application may be considered, and they have eliminated the previous practice of assigning different late application windows to different funding mechanisms, or in some cases, not allowing them at all. Now, all … Read More
While you were enjoying your holidays, Sally Rockey announced last week that the NIH really, truly is implementing the new 5-page biosketch format with the annotated bibliography section detailing the importance of your contributions to science. This format applies to projects beginning in 2016, but that means applications with due dates as early as January 2015–so it’s not too soon to start preparing. This change will require you to spend some time thinking about, rewriting, … Read More
The revision is designed to make the distinction between clinical trials and clinical research studies clearer and to enhance the precision of the information NIH collects, tracks, and reports on clinical trials. It is not intended to expand the scope of the category of clinical trials. No changes have been made to the NIH definition of a “Phase III clinical trial.” The revised NIH definition of “clinical trial” is: A research study1 in which one … Read More